MDM2 gene amplification as a predictive biomarker for the MDM2 inhibitor milademetan

被引：0
|
作者：
Tirunagaru, Vijaya G.
Gounder, Mrinal M.
Kumar, Prasanna R.
Hong, David S.
Doebele, Robert C.
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2021年 / 20卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-21-P210
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P210
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Genetic alterations in breast cancer associated with MDM2 dependency and sensitivity to the MDM2 inhibitor milademetan
    Bidard, Francois-Clement
    Roufai, Diana Bello
    Medford, Arielle J.
    Tirunagaru, Vijaya
    Doebele, Robert C.
    Bardia, Aditya
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [2] The MDM2 gene amplification database
    Momand, J
    Jung, D
    Wilczynski, S
    Niland, J
    [J]. NUCLEIC ACIDS RESEARCH, 1998, 26 (15) : 3453 - 3459
  • [3] Amplification and overexpression of mdm2 gene in ependymomas
    Suzuki, SO
    Iwaki, T
    [J]. MODERN PATHOLOGY, 2000, 13 (05) : 548 - 553
  • [4] MDM2 GENE AMPLIFICATION IN METASTATIC OSTEOSARCOMA
    LADANYI, M
    CHA, C
    LEWIS, R
    JHANWAR, SC
    HUVOS, AG
    HEALEY, JH
    [J]. CANCER RESEARCH, 1993, 53 (01) : 16 - 18
  • [5] MDM2 gene amplification in esophageal carcinoma
    Michalk, Maike
    Meinrath, Jeannine
    Kuenstlinger, Helen
    Koitzsch, Ulrike
    Drebber, Uta
    Merkelbach-Bruse, Sabine
    Bollschweiler, Elfriede
    Kloth, Michael
    Hartmann, Wolfgang
    Hoelscher, Arnulf
    Quaas, Alexander
    Grimminger, Peter P.
    Odenthal, Margarete
    [J]. ONCOLOGY REPORTS, 2016, 35 (04) : 2223 - 2227
  • [6] Binding of an inhibitor of the p53/MDM2 interaction to MDM2
    Duncan, SJ
    Cooper, MA
    Williams, DH
    [J]. CHEMICAL COMMUNICATIONS, 2003, (03) : 316 - 317
  • [7] Clinical Activity and Exploratory Resistance Mechanism of Milademetan, an MDM2 Inhibitor, in Intimal Sarcoma with MDM2 Amplification: An Open-Label Phase Ib/II Study
    Koyama, Takafumi
    Shimizu, Toshio
    Kojima, Yuki
    Sudo, Kazuki
    Okuma, Hitomi Sumiyoshi
    Shimoi, Tatsunori
    Ichikawa, Hitoshi
    Kohsaka, Shinji
    Sadachi, Ryo
    Hirakawa, Akihiro
    Yoshida, Akihiko
    Ando, Reiko Makihara
    Ueno, Toshihide
    Yanagaki, Mitsuru
    Matsui, Naoko
    Nakamura, Kenichi
    Yamamoto, Noboru
    Yonemori, Kan
    [J]. CANCER DISCOVERY, 2023, 13 (08) : 1814 - 1825
  • [8] Population Pharmacokinetics and Exposure-Response Analyses of an MDM2 Inhibitor Milademetan
    Kang, Dongwoo
    Kumar, Prasanna
    Zernovak, Oleg
    Song, Saeheum
    Xiong, Yuan
    Bergsma, Tim
    Lovern, Mark
    Yin, Ophelia
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S24 - S24
  • [9] Amplification of MDM2 and MDM4 in Osteosarcoma
    Duhamel, L.
    Ye, H.
    Halai, D.
    Idowu, B.
    Presneau, N.
    Flanagan, A.
    [J]. JOURNAL OF PATHOLOGY, 2010, 222 : S11 - S11
  • [10] Prospective Validation of MDM2/CEP12 Ratio in the Diagnosis of Sarcomas with MDM2 Gene Amplification
    Mantilla, Jose
    Carlson, Austin
    Donovan, Christine
    Swanson, Paul
    Ricciotti, Robert
    [J]. LABORATORY INVESTIGATION, 2023, 103 (03) : S1726 - S1726
12345